A protein called Skp2, overexpressed in many types of cancer, for
years has gotten away with promoting tumor growth and progression
unhindered by effective treatments.
Hui-Kuan Lin, Ph.D., of Molecular and Cellular Oncology, has spent
the last decade characterizing Skp2 and how it fuels cancer growth,
and the past five years looking for a way to shut it down.
Lin teamed with Shuxing Zhang, M.D., Ph.D., in Experimental Therapeutics...